Clinical trial
Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer
NCT06585007
Study timeline
Study start (actual)2023-12-19Date precision: day
Registry last updated2024-09-05
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Castration-resistant Prostate Cancerunresolved
Oligoprogressiveunresolved
Interventions
RadiotherapyRADIATION
metastasectomyPROCEDURE
Sponsors & collaborators
Universitaire Ziekenhuizen KU Leuvenlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06585007 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.